ArticleJCEM case reports2025
Euglycemic Diabetic Ketoacidosis and Thyroid Storm Occurring During Dapagliflozin Treatment.
Article in JCEM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Euglycemic diabetic ketoacidosis (EDKA) is a type of DKA whose incidence has increased in recent years because of the widespread use of sodium-glucose transport protein 2 inhibitors in diabetes treatment. However, the concomitant occurrence of a thyroid storm is uncommon, easily misdiagnosed and missed, and has a high risk of death. This report described the case of a 46-year-old woman with type 2 diabetes mellitus who used a sodium-glucose transport protein 2 inhibitor to manage her blood glucose levels. Before undergoing hysteroscopic surgery for a uterine mass, she developed EDKA and thyroid storm after experiencing nausea, vomiting, and a high fever with persistent tachycardia. This report summarizes and analyzes the clinical characteristics, diagnosis, and treatment process and outcomes to accumulate clinical experience and improve clinicians' understanding of this acute and life-threatening disease. Timely and appropriate treatment may help reduce the incidence of morbidity and mortality associated with EDKA and thyroid storm.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.